Proximal tumors are associated with greater mortality in colon cancer

Journal of General Internal Medicine

Volumn 25, Issue 11, 2010, Pages 1157-1163

  Wong, Robert ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

Cancer screening; Colorectal cancer; Epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RACE DIFFERENCE; SEX DIFFERENCE;

ADULT; AGE FACTORS; COHORT STUDIES; COLON; COLONIC NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEX CHARACTERISTICS; SURVIVAL RATE; UNITED STATES;

EID: 78650179283     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1460-4     Document Type: Article

References (36)

1. American Cancer Society. Cancer Facts and Figures 2009. Atlanta: American Cancer Soc; 2009. Accessed at http://www.cancer.org/Re search/ CancerFactsFigures/index on July 3, 2010.
2. Levin B, LiebermanDA,McFarland B,SmithRA,BrooksD, AndrewsKS, et al. American Cancer Society Colorectal Cancer Advisory Group. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58: 130-60.
3. Cooper GS, Yuan Z, Landefeld S, et al. A national population based study of incidence of colorectal cancer and age. Cancer. 1995;75:775-81.
4. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med. 1993;329:1977-81. (Pubitemid 24015040)
5. Singh SM, Paszat LF, Li C, He J, Vinden C, Rabeneck L. Association of socioeconomic status and receipt of colorectal cancer investigations: a population-based retrospective cohort study. CMAJ. 2004;171:461-5. (Pubitemid 39179607)
6. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93. (Pubitemid 38519418)
7. Agrawal S, Bhupinderjit A, Bhutani M, et al. Colorectal cancer in African Americans. Am J Gastroenterol. 2005;100:515-23. (Pubitemid 40487546)
8. Chu KC, Miller B, Springfield S. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc. 2007;99:1092-1104. (Pubitemid 47616204)
9. Irby K, Anderson W, Henson D, et al. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol Biomarkers Prev. 2006;15:792-97.
10. Carethers JM. Race and ethnic factors in the genetic pathogenesis of colorectal cancer. J Assoc Acad Minor Phys. 1999;10:59-67.
11. Wong RJ. Marked variations in colon cancer epidemiology: sex-specific and race/ethnicity-specific disparities. Gastroenterol Res. 2009;5:268-76.
12. Rabeneck L, Davila JA, El-Serag HB. Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003;98:1400-09. (Pubitemid 36741541)
13. Cucino C, Buchner AM, Sonnenberg A. Continued rightward shift of colorectal cancer. Dis Colon Rectum. 2002;45:1035-40.
14. Rabeneck L, Lewis JD, Paszat LF, Saskin R, Stukel TA. Risk of proximal and distal colorectal cancer following flexible sigmoidoscopy: a population-based cohort study. Am J Gastroenterol. 2008;108:2075-82.
15. Lakoff J, Paszat LF, Saskin R, Rabeneck L. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population- based study. Clin Gastroenterol Hepatol. 2008;6:1117-21.
16. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1-8.
17. Bressler B, Paszat LF, Vinden C, Li C, He J, Rabeneck L. Colonoscopic miss rates for right-sided colon cancer: a population-based analysis. Gastroenterology. 2004;127:452-6. (Pubitemid 39091893)
18. Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. 2008;359:1218-24.
19. Ries LAG, Melbert D, Krapcho M, et al., eds. SEER cancer statistics review, 1975-2005. Bethesda, MD: National Cancer Institute; 2008.
20. Surveillance, Epidemiology, and End Results (SEER) Program Public Use CD-ROM. (1973-2005). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008.
21. World Health Organization. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
22. Young JL, Roffers SD, Ries LAG, et al., eds. SEER Summary Staging Manual-2000: Codes and Coding Instructions. Bethesda, MD: National Cancer Institute; 2001.
23. Silva IS. Cancer Epidemiology: Principles and Methods. Geneva, Switzerland: World Health Organization; 2001.
24. Gervaz P, Bucher P, Morel P. Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol. 2004;88:261-266. (Pubitemid 39601269)
25. Chirieac LR, Shen L, Catalano PJ, et al. Phenotype of microsatellitestable colorectal carcinomas with CpG island methylation. Am J Surg Pathol. 2005;29:429-436. (Pubitemid 40411172)
26. Konishi K, Fujii T, Boku N, et al. Clinicopathological differences between colonic and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut. 1999;45:818-821.
27. Hurlstone DP, Cross SS, Adam I, et al. A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom. Am J Gastroenterol. 2003;98:2543-2549. (Pubitemid 37448769)
28. Ross AS, Waxman I. Flat and depressed neoplasms of the colon in western populations. Am J Gastroenterol. 2006;101:172-180. (Pubitemid 43381726)
29. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterol. 2010;138:2073-2087.
30. Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labranci R, Hamilton SR. Defective mismatch repair as a predictive marker for lack of efficacy of Fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010 [E-pub ahead of print] PMID:20498393.
31. Mchutchinson L, Poynard T, Pianko S, et al. The impact of interferon plus ribivirin on response to therapy in blacks with chronic hepatitis C. Gastroenterology. 2000;119:1317-23.
32. Park IU, Taylor AL. Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review. Ann Fam Med. 2007;5:444-52. (Pubitemid 47535976)
33. The ALLHAT Officers Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the antihypertensive and lipidlowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;228:2891-97.
34. Gibbs CR, Beevers DG, Lip GY. The management of hypertensive disease in black patients. Q J Med. 1999;92:187-92. (Pubitemid 29184881)
35. Wong RJ, Corley DA. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci. 2009;54:2031-2039.
36. Wong RJ. Marked Variations in Proximal Colon Cancer Survival by Race/Ethnicity Within the United States. J Clin Gastroenterol. 2009 [Epub ahead of print] PMID: 19996985